Your browser doesn't support javascript.
loading
Enhancement of the IFN-ß-induced host signature informs repurposed drugs for COVID-19.
Huang, Chen-Tsung; Chao, Tai-Ling; Kao, Han-Chieh; Pang, Yu-Hao; Lee, Wen-Hau; Hsieh, Chiao-Hui; Chang, Sui-Yuan; Huang, Hsuan-Cheng; Juan, Hsueh-Fen.
Affiliation
  • Huang CT; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, Taiwan.
  • Chao TL; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Kao HC; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Pang YH; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Lee WH; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Hsieh CH; Department of Life Science, National Taiwan University, Taipei 10617, Taiwan.
  • Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, Taiwan.
  • Huang HC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan.
  • Juan HF; Institute of Biomedical Informatics, National Yang-Ming University, Taipei 11221, Taiwan.
Heliyon ; 6(12): e05646, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33289002

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2020 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2020 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom